Does RISANKIZUMAB-RZAA Cause Pustular psoriasis? 26 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Pustular psoriasis have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
26
Reports of Pustular psoriasis with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
1
Deaths
15
Hospitalizations
How Dangerous Is Pustular psoriasis From RISANKIZUMAB-RZAA?
Of the 26 reports, 1 (3.8%) resulted in death, 15 (57.7%) required hospitalization, and 2 (7.7%) were considered life-threatening.
Is Pustular psoriasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Pustular psoriasis?
ADALIMUMAB (685)
SECUKINUMAB (417)
METHOTREXATE (389)
ETANERCEPT (345)
INFLIXIMAB (326)
CERTOLIZUMAB PEGOL (310)
HYDROXYCHLOROQUINE (276)
USTEKINUMAB (276)
GOLIMUMAB (258)
LEFLUNOMIDE (245)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Pustular psoriasis Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA